Dr. Cocoa for Children

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the reduction of fever and the relief of minor aches and pains associated with various conditions, including the common cold, influenza, headache, sore throat, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the medication is administered according to the following guidelines. Prior to use, the product must be shaken well to ensure proper mixing.

Dosing should be determined using the provided dosing chart, with weight being the preferred method for calculating the appropriate dose. If weight is not available, age may be used as an alternative.

To administer the dose, the child protective cap should be removed, and the prescribed amount should be poured into the enclosed dosing cup specifically designed for this product. It is imperative that no other dosing device is utilized to avoid inaccuracies.

The dose may be repeated every 4 hours as needed while symptoms persist. However, it is crucial not to exceed 5 doses within a 24-hour period.

Healthcare professionals should advise caregivers to adhere strictly to these instructions and to consult a physician if there are any uncertainties or if symptoms do not improve. Additionally, caregivers should be reminded not to exceed the recommended dosage, as an overdose may occur.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• In patients with a known allergy to acetaminophen or any of the inactive ingredients in this product, as this may lead to severe allergic reactions.

• Exceeding the recommended dose while using this product is contraindicated, as it poses a risk of overdose.

Warnings and Precautions

Severe liver damage may occur in children taking this product, which contains acetaminophen, if they exceed five doses within a 24-hour period or if they are concurrently using other medications that contain acetaminophen. Healthcare professionals should be vigilant regarding this risk and ensure that dosing guidelines are strictly followed.

Acetaminophen has been associated with severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a physician is advised to rule out serious underlying conditions.

Healthcare providers should inquire about the patient's medical history, particularly regarding liver disease, prior to recommending this product. Additionally, it is essential to consult with a doctor or pharmacist if the child is currently taking warfarin, a blood-thinning medication, to avoid potential interactions.

It is critical to adhere to the recommended dosing guidelines to prevent overdose. In the event of an overdose, immediate medical attention is necessary. Patients or caregivers should contact a Poison Control Center at (1-800-222-1222) without delay, as timely intervention is crucial for both adults and children, even in the absence of noticeable symptoms.

Patients should be advised to discontinue use and consult a healthcare professional if pain worsens or persists beyond five days, if fever intensifies or lasts more than three days, if new symptoms arise, or if there is any redness or swelling. These signs may indicate a serious condition requiring further evaluation.

Side Effects

Severe adverse reactions associated with this product include the potential for severe liver damage, particularly in patients who exceed the maximum daily dosage of five doses within a 24-hour period or who concurrently use other medications containing acetaminophen. Patients should be aware that acetaminophen may also lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use and seek immediate medical assistance.

Patients experiencing a severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, should consult a healthcare professional promptly.

It is advised that this product not be used in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. Patients should confirm the absence of acetaminophen in other medications with a healthcare provider or pharmacist if uncertain. Additionally, this product should not be administered to individuals with a known allergy to acetaminophen or any of the inactive ingredients present.

Before using this product, patients with liver disease should seek medical advice. Furthermore, those taking the anticoagulant warfarin should consult a healthcare professional or pharmacist prior to use.

Patients are cautioned to adhere strictly to the recommended dosage and to discontinue use and consult a doctor if pain worsens or persists beyond five days, if fever worsens or lasts more than three days, if new symptoms arise, or if redness or swelling occurs, as these may indicate a serious condition.

In the event of an overdose, immediate medical attention is crucial. Patients should contact a Poison Control Center or seek medical help right away, even if no signs or symptoms are apparent, as prompt intervention is essential for both adults and children.

Drug Interactions

Acetaminophen has been observed to enhance the anticoagulant effects of warfarin, which may result in an elevated risk of bleeding. It is recommended that the International Normalized Ratio (INR) be monitored closely in patients receiving both acetaminophen and warfarin to ensure safe and effective management of anticoagulation therapy.

No additional drug interactions or laboratory test interactions have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Cocoa for Children (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 to 11 years may be treated with this medication, which contains 160 mg of acetaminophen per 5 mL. Dosing should primarily be based on the child's weight; if weight is not available, age may be used as a guide. The recommended dosing frequency is every 4 hours as needed, with a maximum of 5 doses within a 24-hour period.

Healthcare professionals should advise caregivers to consult a doctor before administering this medication if the child has liver disease or is concurrently taking the anticoagulant warfarin. It is crucial to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, immediate medical assistance or contact with a Poison Control Center is essential.

Geriatric Use

Elderly patients are not specifically addressed in the prescribing information for Dr. Cocoa for Children Pain and Fever (acetaminophen liquid). The product is indicated for use exclusively in children aged 2 to 11 years.

As there are no dosage adjustments, safety concerns, or special precautions outlined for geriatric patients, healthcare providers should exercise clinical judgment when considering the use of this product in elderly individuals. Monitoring for potential adverse effects is advisable, given the lack of specific data regarding this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. There are no stated safety concerns or contraindications related to pregnancy. Additionally, no dosage modifications for pregnant individuals are mentioned, and the insert does not include any special precautions regarding the use of this product during pregnancy. Healthcare professionals should consider the absence of data when advising pregnant patients or women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if there is a concurrent liver disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of renal impairment.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical to adhere to the maximum daily dosage, which is limited to 5 doses within a 24-hour period. Exceeding this limit or concomitant use with other medications containing acetaminophen may significantly increase the risk of liver injury.

Before administration, it is advisable for caregivers to consult a healthcare professional if the patient has a history of liver disease. This precaution is essential to ensure the safety and efficacy of the treatment in patients with compromised liver function. Regular assessment of liver function may be warranted in these cases to prevent potential adverse effects.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at (1-800-222-1222). Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the timely recognition and management of overdose situations can significantly impact patient outcomes. Therefore, it is essential to remain vigilant and proactive in addressing potential overdose cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. Reported symptoms include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised that the use of acetaminophen be discontinued and medical assistance be sought immediately.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, it is crucial to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222, as prompt medical attention is essential for both adults and children, even if no signs or symptoms are apparent.

Patients should be informed not to use this medication in conjunction with any other drug that contains acetaminophen, whether prescription or nonprescription. If there is any uncertainty regarding the presence of acetaminophen in other medications, patients are encouraged to consult with a doctor or pharmacist.

It is important to instruct patients not to use this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. Patients should also be advised to discontinue use and consult a doctor if pain worsens or persists for more than 5 days, if fever worsens or lasts more than 3 days, or if new symptoms arise, including redness or swelling, as these may indicate a serious condition.

While using this product, patients must not exceed the recommended dose, and they should be made aware of the overdose warning. Additionally, healthcare providers should recommend that patients consult a doctor before use if their child has liver disease or is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in a configuration that includes an NDC number for identification. It should be stored at a controlled room temperature, specifically between 20-25ºC (68-77ºF).

It is imperative to ensure that the printed inner seal under the cap is intact; the product should not be used if this seal is torn or missing. Proper handling and storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally, with a recommended repeat dose every 4 hours as long as symptoms persist, not to exceed 5 doses within a 24-hour period. Clinicians should counsel patients to consult a doctor before use if the child has liver disease or is taking the anticoagulant warfarin.

Patients should be advised to discontinue use and seek medical advice if pain worsens or persists beyond 5 days, if fever intensifies or lasts more than 3 days, if new symptoms arise, or if there is any redness or swelling.

Drug Information (PDF)

This file contains official product information for Dr. Cocoa for Children, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)